Atlas Trials

NKGen Biotech, Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NKGen Biotech, Inc.

RecordFirmDate
Open-Label Extension Protocol to SNK01-AD01 Study (NCT07228078)NKGen Biotech, Inc.2025-06-30
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease (NCT06189963)NKGen Biotech, Inc.2023-11-21
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy (NCT05990920)NKGen Biotech, Inc.2023-08-23
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers (NCT05099549)NKGen Biotech, Inc.2021-11-03
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers (NCT04464967)NKGen Biotech, Inc.2021-03-01
Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD) (NCT04678453)NKGen Biotech, Inc.2021-01-06
Autologous Natural Killer Cells in Subjects With Plaque Psoriasis (NCT03894579)NKGen Biotech, Inc.2019-07-18
Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy (NCT03941262)NKGen Biotech, Inc.2019-07-15

Track NKGen Biotech, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.